NCT05323799

Brief Summary

The Australian government swift interventions and actions early to the COVID 19 epidemic included enforced quarantine, isolation, varying degrees of social and physical distancing measures, travel restrictions, community level testing and enhanced contact tracing models which effected the trajectory of the epidemic impact. While the search for effective therapeutics and vaccines continues, it is important to understand how to effectively implement and optimise the current public health interventions available; application of traditional contact tracing , contributions of new contact tracing mobile phone applications, community level testing and use of specific fit for purpose diagnostic tests; to screen, detect and provide evidence of infection clearance. While the suppression measures have been effective on disease transmission rates, it has had economic, social and non COVID-19 health costs impacts. As community restrictions change it will be important to monitor and evaluate the effectiveness of these key interventions. This is a longitudinal study that will follow the experience and behaviors of 2 key risk populations impacted by COVID-19 transmission containment measures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2020

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 12, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

3.8 years

First QC Date

April 6, 2022

Last Update Submit

October 18, 2023

Conditions

Outcome Measures

Primary Outcomes (5)

  • Change from response in baseline questionnaires to Adherence (non-adherence) with COVID19 transmission containment measures

    Participants will complete questionnaires and diaries as binary daily measure of outcomes of compliance/nonadherence for each individual, determined by their ability to adhere to government regulations

    18 months

  • Change from response in baseline questionnaires depicting what are the unintended health, social and economic consequences of the government response to control COVID19 transmission

    Using data from baseline and follow up questionnaires the researchers will calculate both an individual and a composite variable to assess the following unintended consequence, including: * Loss of job during COVID-19 period * Decline in income during COVID-19 period * Disruption to schooling or education during COVID-19 period * Decline in work productivity during COVID-19 period * Change in responsibilities to care for others * Decrease in healthcare utilization during COVID-19 period * Increase in alcohol (frequency or quantity) and other drug consumption during COVID-19 period * Change in mental health or personal wellbeing during COVID-19 period * Increase in social connectedness during COVID-19 period A scale is not being applied in above responses; options for response are in place. * Anxiety (using GAD scale: https://patient.info/doctor/generalised-anxiety-disorderassessment-gad-7) is a response section in the questionnaire.

    18 months

  • What are the social contacts and mixing patterns of COVID-19 cases

    The questionnaire participants will be ask to complete include nominating the number of contacts per day and the time will permit collation of social network data. Using data from the daily diaries (retrospective and prospective) the researchers will calculate: * Numbers of contacts per day * Numbers of contacts by type of activity * Time spent doing each type of activity per day * Time from symptom onset to self-isolation * Time from symptom onset to accessing diagnostic testing * Time from accessing testing to result receipt (diagnosis) * Time from result receipt (diagnosis) - to contact by contact tracing team A scale is not being used.

    18 months

  • What are the types of social contacts and mixing patterns of COVID-19 cases

    The questionnaire participants will be ask to complete will include nominating the relationship with their contacts per day(i.e. partner, child, friend), and individuals COVID test status, providing detailed specifics of the projects social network data

    18 months

  • Measure of the efficacy of government interventions

    Participants responses to questionnaires, focus group discussions will be used as binary measurers; The researchers will not be using a scale, reporting will be in the format: * Number and % of participants that reported correct knowledge of government guidance regarding isolation, quarantine and physical distancing requirements - calculated as a binary outcome (Yes/No) and also as a combined knowledge score * Number and % of participants that report using COVID-19 prevention measures advised by the Governments. For example: * 560/700 (80%) participants report regularly using hand sanitizer and/or washing hands * 680/700 (97%) of participants report applying physical distancing rules as much as I can (i.e. keeping 1.5 metres away from others, not shaking hands) * Number and % of participants that reported COVID-19 related symptoms that were tested for SARS-CoV-2 infection, and results of these tests

    18 months

Secondary Outcomes (2)

  • Collect and collate empirical data of COVID19 cases, contacts and key vulnerable groups

    18 months

  • Assess the effectiveness of government interventions to reduce COVID-19 transmission from questionnaire responses from cohort participants

    18 months

Study Arms (2)

Group 1/Seed set 1 - recently diagnosed 'COVID-19 cases

(Group1) and their social network with up to 2 waves of /Key people, will be followed up for 1 month initially with specific monitoring tools before they will transition into ongoing follow up and monitoring as recruitment group 2

Group 2/Seed set 2 - people from the general community that are not currently infected with COVID19

'Group 2' that are practicing physical distancing and represent specific key risk groups, and their social network with up to 2 waves of Key people

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Volunteer participants over the age of 18 years in Victoria, Australia

You may qualify if:

  • Community participants

You may not qualify if:

  • Unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Macfarlane Burnet Institute for Medical Research and Public Health

Melbourne, Victoria, 3004, Australia

Location

Related Publications (1)

  • Pedrana A, Bowring A, Heath K, Thomas AJ, Wilkinson A, Fletcher-Lartey S, Saich F, Munari S, Oliver J, Merner B, Altermatt A, Nguyen T, Nguyen L, Young K, Kerr P, Osborne D, Kwong EJL, Corona MV, Ke T, Zhang Y, Eisa L, Al-Qassas A, Malith D, Davis A, Gibbs L, Block K, Horyniak D, Wallace J, Power R, Vadasz D, Ryan R, Shearer F, Homer C, Collie A, Meagher N, Danchin M, Kaufman J, Wang P, Hassani A, Sadewo GRP, Robins G, Gallagher C, Matous P, Roden B, Karkavandi MA, Coutinho J, Broccatelli C, Koskinen J, Curtis S, Doyle JS, Geard N, Hill S, Coelho A, Scott N, Lusher D, Stoove MA, Gibney KB, Hellard M. Priority populations' experiences of isolation, quarantine and distancing for COVID-19: protocol for a longitudinal cohort study (Optimise Study). BMJ Open. 2024 Jan 12;14(1):e076907. doi: 10.1136/bmjopen-2023-076907.

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Margaret Hellard

    The Macfarlane Burnet Institute for Medical Research and Public Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 12, 2022

Study Start

September 30, 2020

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

October 23, 2023

Record last verified: 2023-10

Locations